Medication info
Fosnel Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Fosnel Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.2mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 200800316 · Notified 2008.01.08 · Insurance code 653401610

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 35 mg of risedronate sodium orally once weekly. No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. Because food interferes with the absorption of this drug, take it at least 30 minutes before breakfast for adequate absorption, or at least 2 hours before or after consuming any food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it with an adequate amount of plain water (170 ∼ 230 mL) while in an upright position. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy of this drug in children under 18 years of age have not been established.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men. Osteoporosis is a condition that weakens bones, making them susceptible to fractures; this medication can strengthen bones and reduce the risk of fractures. Therefore, it is effective in improving bone density and preventing fractures.

How to take

Adult dose

Adults: Administer 35 mg of risedronate sodium orally once weekly. No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. Because food interferes with the absorption of this drug, take it at least 30 minutes before breakfast for adequate absorption, or at least 2 hours before or after consuming any food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it with an adequate amount of plain water (170 ∼ 230 mL) while in an upright position. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy of this drug in children under 18 years of age have not been established.

Precautions

This medication may irritate the mucous membranes of the esophagus and stomach, so patients with problems in the esophagus or stomach should exercise caution when taking it. If symptoms such as difficulty swallowing, chest pain, or heartburn occur while taking the medication, discontinue use immediately and consult a physician. Take this medication while sitting or standing, with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. This medication should not be taken by patients with certain esophageal diseases, hypocalcemia, severe renal impairment, or by women who are pregnant or breastfeeding. Taking medications or food that contain divalent cations such as calcium, magnesium, or iron together with this medication can interfere with absorption, so maintain a time gap before and after taking this medication. This medication is used for the treatment of osteoporosis, and taking calcium and vitamin D together can help enhance effectiveness and safety. There may be rare but serious side effects with long-term use such as femoral fractures or osteonecrosis of the jaw; continuous observation of symptom changes is necessary. It is important to maintain a fasting state for a certain time before and after taking this medication, and do not chew or suck on the tablet. Avoid taking this medication during pregnancy or breastfeeding, and consult a physician if necessary. Elderly patients can take this medication similarly to adults; however, caution may be needed based on individual conditions. Overdosage may lead to hypocalcemia, which requires appropriate treatment. This medication should be stored out of reach of children, and it is advisable not to change the container.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • infection
  • low back pain
  • accidental injury
  • pain
Show 58 more
  • abdominal pain
  • flu symptoms
  • headache
  • fatigue
  • throat pain
  • chest pain
  • allergic reaction
  • hypertension
  • constipation
  • diarrhea
  • dyspepsia
  • nausea
  • peripheral edema
  • arthralgia
  • arthritis
  • fracture
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • discomfort in the chest
  • palpitations
  • increased sweating
  • flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • mucous membrane syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • skin reactions
  • bone pain
  • jaw necrosis
  • external auditory canal osteonecrosis
  • uveitis
  • scleritis
  • iritis
  • liver dysfunction
  • jaundice
  • ocular pain

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in an airtight container to prevent air exposure, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness safely.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.